COVID-19 can cause numbness and tingling, and these sensory symptoms are far more common than many people realize. In studies of long COVID patients, numbness or tingling (clinically called paresthesia) has been reported in roughly a third to nearly 60 percent of those surveyed, depending on the population studied and how far out from infection the data were collected. The symptom can appear during acute illness, emerge weeks later, or persist for months to years as part of long COVID. What makes this particularly frustrating for patients is that the numbness can stem from several different mechanisms, not all of which are well understood or easy to diagnose.
How Common Is Numbness After COVID-19
Paresthesia, the medical term for abnormal sensations like numbness, tingling, pins-and-needles, or burning, ranks among the more frequently reported neurological symptoms of long COVID. A systematic review and meta-analysis that pooled data from multiple studies found a pooled prevalence of about 33 percent for paresthesia among post-discharge COVID patients.1PubMed Central. Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis A separate large survey that specifically assessed neurological symptom severity in long COVID found numbness and tingling in close to 59 percent of respondents.2Frontiers in Neurology. Prevalence and severity of neurologic symptoms in Long-COVID and the role of pre-existing conditions, hospitalization, and mental health The gap between those two figures reflects differences in who was studied and when, but the takeaway is consistent: numbness is not a rare or fringe complaint. It sits alongside fatigue, brain fog, and headache as one of the hallmarks of long COVID’s neurological profile.
These numbers also undercount the issue to some degree, because many people with mild or intermittent tingling never mention it to a doctor. Some assume it will resolve on its own, and for many it does. But for a significant minority, paresthesia becomes a chronic problem that interferes with daily life, particularly when it affects the hands and feet.
Small Fiber Neuropathy as a Key Driver
One of the clearest explanations for persistent numbness after COVID involves damage to the smallest nerve fibers in the skin and organs. Small fiber neuropathy, or SFN, affects the thin unmyelinated and thinly myelinated nerve fibers responsible for sensing pain, temperature, and light touch. When these fibers are damaged or destroyed, the result is numbness, burning, tingling, or stabbing pain, often starting in the feet and hands.
A prospective study comparing post-COVID patients with healthy controls found that 94 percent of post-COVID patients tested had reduced small nerve fiber density on skin biopsy, confirming SFN.3PubMed Central. Small fiber neuropathy associated with COVID‐19 infection and vaccination: A prospective case–control study Earlier case series work similarly confirmed SFN through skin biopsy in patients whose standard nerve conduction studies came back normal, which is a critical point: conventional electrodiagnostic testing often misses small fiber damage entirely.4PubMed Central. Small fiber neuropathy associated with SARS-CoV-2 infection This means patients can have very real nerve damage that routine testing does not detect, leading to frustration and sometimes dismissal of their symptoms.
An emerging noninvasive tool called corneal confocal microscopy, which images tiny nerve fibers in the cornea of the eye, has shown measurable nerve fiber loss in long COVID patients, particularly those with neurological symptoms.5PubMed. Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID Because this technique is quick and painless compared to a skin biopsy, it could eventually become a more accessible way to objectively document nerve damage in these patients.
Why the Virus Damages Nerves
There is no single mechanism behind COVID-related numbness. Research has identified at least four overlapping pathways, and in any given patient, more than one may be at work.
Direct Viral Invasion of Sensory Neurons
SARS-CoV-2 can directly infect peripheral sensory and autonomic neurons. The virus enters through receptors found on pain-sensing nerve cells in structures called dorsal root ganglia, which sit just outside the spinal cord and relay sensory information from the body to the brain.6PubMed Central. ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects Animal studies have shown that SARS-CoV-2 rapidly invades peripheral nerves even before the virus reaches detectable levels in the bloodstream, and that this invasion results in sensory symptoms consistent with what COVID patients report.7PubMed Central. SARS-CoV-2 Rapidly Infects Peripheral Sensory and Autonomic Neurons, Contributing to Central Nervous System Neuroinvasion before Viremia Lab work using human sensory neurons grown from stem cells confirmed that these cells can be infected by multiple SARS-CoV-2 variants, though interestingly the neurons appear unable to produce new infectious virus particles, suggesting the damage may come from the infection itself rather than from ongoing viral replication.8iScience. Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2
Autoimmune Attack on Nerve Tissue
A growing body of evidence points to immune dysregulation as a common thread behind post-COVID neuropathy.9PubMed Central. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID A landmark 2025 study in Cell demonstrated this in striking fashion. Researchers found that long COVID patients produce a diverse array of autoantibodies, some of which target proteins in the central and peripheral nervous system. When purified antibodies from these patients were transferred into mice, the animals developed fatigue-like behavior, loss of coordination, heightened pain sensitivity, and measurable small fiber nerve damage, essentially recreating the patients’ symptoms in an animal model.10Cell. Transfer of IgG from long COVID patients induces symptomology in mice This is some of the strongest evidence to date that autoantibodies play a causal, not just correlative, role in long COVID nerve symptoms.
Microvascular Damage
COVID-19 is well known for damaging the inner lining of blood vessels. During acute infection, this endothelial damage promotes tiny blood clots and disrupts barriers throughout the body, including the blood-brain barrier.11PubMed Central. Damage to endothelial barriers and its contribution to long COVID Peripheral nerves depend on healthy blood flow from tiny blood vessels to function. If the microvascular supply to a nerve is impaired, the nerve starves and begins to malfunction. Researchers have proposed that impaired microvascular perfusion of peripheral nerves may be a primary mechanism behind lingering neuropathy in long COVID.12PubMed Central. The microvascular hypothesis underlying neurologic manifestations of long COVID-19 and possible therapeutic strategies
Central Sensitization
Not all numbness and tingling originates in the peripheral nerves. Some long COVID patients develop central sensitization, a state in which the brain and spinal cord become hypersensitive to sensory input. In this condition, signals that should feel normal get amplified into pain or altered sensation. Research has found that central sensitization appears highly prevalent among long COVID patients and may be driven by reduced blood flow in the brain and ongoing neuroinflammation.13PubMed. Central sensitization in long COVID: Associations with autonomic symptom burden, cerebral hypoperfusion, and neuroinflammation Survey data have similarly suggested that symptoms consistent with central sensitization, including heightened sensitivity to light, sound, and touch alongside pain and paresthesia, are common in people recovering from COVID.14PubMed Central. Is Central Sensitisation the Missing Link of Persisting Symptoms after COVID-19 Infection? This matters because central sensitization does not show up on a skin biopsy or nerve conduction test, which can make it particularly hard to diagnose.
When Numbness Involves the Face
Numbness does not always start in the hands and feet. Some COVID patients develop numbness or altered sensation in the face, often involving the trigeminal nerve, which provides sensation to the forehead, cheeks, and jaw. Case reports describe patients developing facial numbness days after COVID symptoms, with MRI scans revealing inflammation along the trigeminal nerve itself.15PubMed Central. Post COVID-19 trigeminal neuritis: Case report Other patients have presented with trigeminal neuropathic pain, diagnosed through clinical exam and sensory testing, with no other explanation besides the temporal link to their SARS-CoV-2 infection.16PubMed Central. Trigeminal neuropathy presenting secondary to SARS-CoV-2 infection
Facial numbness understandably triggers alarm because patients worry about stroke. The key distinction is timing and progression. Post-COVID trigeminal neuropathy tends to develop gradually over days, often after the acute respiratory illness has improved, and follows a nerve distribution pattern rather than affecting an entire side of the face and body the way a stroke would. That said, anyone experiencing sudden-onset facial numbness should seek emergency evaluation regardless of their COVID history.
Guillain-Barré Syndrome and COVID-19
Guillain-Barré syndrome, a condition in which the immune system attacks the peripheral nerves and causes progressive weakness and numbness, was one of the earliest neurological complications recognized in COVID patients. The most common form seen in these cases has been the classic sensory-motor type, with demyelinating and mixed variants observed more often than pure axonal damage.17Frontiers in Neurology. COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature A systematic review of COVID-associated GBS cases confirmed this pattern.18PubMed Central. Guillain–Barré syndrome associated with COVID-19: A systematic review
However, the picture is more complicated than early reports suggested. A large epidemiological study found no clear statistical association between COVID-19 and GBS at a population level, and GBS rates actually appeared to drop during the pandemic, possibly because public health measures reduced circulation of other infections that more commonly trigger the condition.19Frontiers in Neurology. Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections This does not mean COVID never triggers GBS, but it does suggest the risk for any individual patient is low. GBS is worth mentioning because it is one of the few post-COVID numbness scenarios that constitutes a medical emergency requiring rapid treatment.
Numbness From ICU Treatment, Not the Virus Itself
There is another pathway to numbness that has nothing to do with immune responses or nerve infection. Patients who were severely ill with COVID and spent extended time in intensive care, particularly in the prone (face-down) position used to improve breathing, developed nerve compression injuries at alarming rates. This positioning can compress nerves in the arms, shoulders, and legs, leading to weakness, pain, and numbness in the affected limbs.20PubMed Central. Nerve Compression Injuries After Prolonged Prone Position Ventilation in Patients With SARS-CoV-2: A Case Series Brachial plexus injuries, affecting the network of nerves that serve the arm, were reported in multiple case series of critically ill COVID patients.21American Journal of Physical Medicine & Rehabilitation. Brachial Plexus Neuropathies During the COVID-19 Pandemic: A Retrospective Case Series of 15 Patients in Critical Care
This distinction matters because the treatment and prognosis for positional nerve compression are quite different from those for autoimmune or viral neuropathy. Compression injuries often improve with physical therapy and time once the pressure is removed, though recovery can take months if the nerve was severely damaged.
What About the Larger Nerve Fibers
Small fiber neuropathy gets the most attention in long COVID discussions, but larger nerve fibers can also be affected. A systematic review of electrophysiological assessments in COVID patients found that about 31 percent had abnormal motor nerve conduction studies and about 4 percent had abnormal sensory nerve conduction studies.22PubMed Central. Electrophysiological assessment in patients with COVID-19-related peripheral neuropathies and myopathies: a systematic review Another study documented measurable reductions in nerve conduction parameters in both sensory and motor fibers that persisted six months after the acute infection.23PubMed Central. Electroneurological changes in peripheral nerves in patients post-COVID Earlier case reports had identified patterns consistent with demyelinating polyneuropathy, where the insulating sheath around nerves deteriorates, leading to slowed or blocked nerve signals.24PubMed Central. Nerve conduction study and electromyography findings in patients recovering from Covid-19 – Case report
The relatively low rate of abnormal sensory nerve conduction studies compared to the high rate of patient-reported numbness reinforces the small fiber neuropathy story: standard electrodiagnostic tests measure large fiber function, so they miss the damage happening in the tiniest nerve endings. A normal nerve conduction study does not rule out neuropathy in a long COVID patient.
Autonomic Symptoms That Travel With Numbness
Many long COVID patients who experience numbness also develop autonomic symptoms, because the small nerve fibers affected are often the same ones that regulate involuntary body functions. This can produce a constellation that includes heart racing upon standing, dizziness, abnormal sweating, temperature sensitivity, and gastrointestinal problems alongside the numbness and tingling. Some of these patients meet criteria for postural orthostatic tachycardia syndrome (POTS) or other forms of dysautonomia.25PubMed Central. Autonomic dysfunction following COVID-19 infection: an early experience One documented POTS case described a patient who experienced lightheadedness, excessive sweating, heat sensitivity, and numbness with tingling in all limbs upon standing.26Autonomic Neuroscience. Autonomic function testing in long-COVID syndrome patients with orthostatic intolerance
If you are experiencing numbness alongside a racing heartbeat when you stand up, unexplained sweating changes, or frequent dizziness, the combination may point toward autonomic nerve involvement rather than a purely sensory problem. This matters for treatment, because autonomic dysfunction has its own management strategies involving hydration, compression garments, medications, and gradual exercise programs.
Treatment and What Seems to Help
Treatment for post-COVID numbness depends heavily on the underlying mechanism, which is precisely why getting the right diagnosis matters. For patients with confirmed small fiber neuropathy that appears to have an autoimmune basis, intravenous immunoglobulin (IVIG) has shown encouraging early results. In one case-control study, all nine patients who received IVIG for post-COVID SFN experienced significant improvement in their neuropathic symptoms, compared to only three out of seven untreated patients.27PubMed Central. Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19 These are small numbers, and larger trials are needed, but the direction of the finding is consistent with the autoimmune hypothesis: if rogue antibodies are driving nerve damage, dampening that immune response helps.
Beyond IVIG, management typically borrows from the standard neuropathy toolkit. Medications like gabapentin and pregabalin can reduce neuropathic pain and abnormal sensations. Duloxetine, an antidepressant that also modulates pain pathways, is another option. Physical therapy can help with balance and functional limitations, particularly for patients with numbness in the feet. Some patients report improvement with time alone, which suggests the nerve fibers can regenerate once the inflammatory insult resolves, though small fiber regrowth is slow and can take many months.
For patients whose numbness is driven by central sensitization rather than peripheral nerve damage, the treatment approach shifts toward strategies that calm an overactive nervous system: graded exercise, cognitive behavioral approaches, sleep optimization, and sometimes low-dose medications that modulate central pain processing. Distinguishing peripheral from central causes, or recognizing when both are present, remains one of the key challenges in managing these patients.
Vaccine-Associated Numbness
Some people developed numbness or tingling after COVID vaccination rather than after infection. A large surveillance report from Quebec covering over 15 million vaccine doses found that numbness or tingling was reported at a rate of about 8 per 100,000 doses administered.28PubMed. New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada Rates were higher after the first dose than the second, and women reported symptoms three to four times more often than men. Most cases were mild to moderate, with a median duration of five days, though about 12 percent of cases lasted one to five months and roughly 1 percent lasted over six months. Symptoms most often appeared in the upper limbs but also frequently involved the lower limbs or face.
Rare isolated cases have been reported as well, including one patient who developed localized thigh numbness hours after vaccination with no other risk factors for nerve compression.29PubMed Central. Meralgia paresthetica mimic after Moderna COVID‑19 vaccine The prospective case-control study comparing post-COVID and post-vaccination patients found small fiber neuropathy in both groups, though it was somewhat more common in those who developed symptoms after infection (94 percent) than after vaccination (79 percent).3PubMed Central. Small fiber neuropathy associated with COVID‐19 infection and vaccination: A prospective case–control study The overlap suggests a shared immune-mediated mechanism, likely involving the spike protein whether encountered through virus or vaccine, though the infection-related pathway appears to carry a higher burden of nerve damage.
What Recovery Looks Like
The trajectory of post-COVID numbness varies widely. Some patients see their symptoms fade within weeks to a few months as inflammation resolves and small fibers begin to regrow. Others deal with symptoms that persist well beyond six months. Electrophysiological abnormalities in larger nerve fibers have been documented persisting at least six months post-infection.23PubMed Central. Electroneurological changes in peripheral nerves in patients post-COVID For small fiber neuropathy, the timeline is harder to pin down because there is less longitudinal data, but clinical experience with SFN from other causes suggests that nerve regrowth happens on the order of months to a year or more when the underlying trigger is controlled.
One thing researchers have noted is that post-COVID neuromuscular symptoms can appear even in patients who never had severe acute illness or any of the dramatic acute complications like Guillain-Barré syndrome or critical illness neuropathy. Persistent paresthesia, autonomic symptoms, and muscle pain can show up in people whose initial infection was mild, and small fiber neuropathy has been identified as a potential underlying cause in these cases.30Wiley Online Library. Persistent post-COVID-19 neuromuscular symptoms This is worth knowing because it counters the assumption that only severely ill patients develop lasting nerve problems. A mild case of COVID can still result in months of tingling hands and feet.
Pre-existing conditions like diabetes, which already predispose someone to neuropathy, can compound the picture and make it harder to determine how much of the symptom burden is new versus pre-existing damage that was pushed past a noticeable threshold. If you had borderline neuropathy before COVID, the infection may have tipped it into a symptomatic range. This is one more reason why working with a neurologist who understands both post-viral syndromes and small fiber neuropathy can be valuable for people whose numbness is not resolving on its own.